Speakers

Co-Chairs

Dominic Adair

Partner
Bristows LLP (U.K)

Remedies and Alternative Measures for Life Sciences Patent Challenges: New Considerations for Injunctions, Corrective Measures, and Rules on Procurement of Evidence

February 24, 2022 • 3:00 pm

Bert Oosting

Partner
Hogan Lovells

Co-Chairs’ Opening Remarks

February 24, 2022 • 9:00 am

Esteemed Faculty

António Andrade

Partner
Abreu Advogados

Proven Strategies for Life Sciences Patent Enforcement: Protecting Patent Rights and Mastering Enforcement Procedures

February 23, 2022 • 10:00 am

Steven Baldwin

Partner
Kirkland & Ellis LLP

European Supplementary Protection Certificates (SPCs): Examining Current Scope, Duration, Requirements and Assessing the Viability of a Unitary SPC

February 23, 2022 • 11:30 am

Eran Bareket

Partner, Head of Legal Practice
Gilat, Bareket & Co., Attorneys at Law

Patent Enforcement Liability Towards Third Parties: What the Life Sciences Industry Needs to Know About Findings of Unjust Enrichment Due to the Invalidation of Previously Valid Patents

February 24, 2022 • 11:30 am

Laëtitia Bénard

Partner
Allen & Overy LLP

Proven Strategies for Life Sciences Patent Enforcement: Protecting Patent Rights and Mastering Enforcement Procedures

February 23, 2022 • 10:00 am

Sara Burghart

Lead IP Litigation Counsel
Global Litigation & Launch – Global IP
Sandoz International GmbH (DEU)

Second Medical Use: Reconciling Infringement and Enforcement

February 23, 2022 • 4:30 pm

Sabrina Duschner

Head of Patent Litigation Strategy
Fresenius Kabi

Plausibility, Sufficiency, and Inventive Step: Special Considerations for Formulation and Combination Patents in the Life Sciences Arena

February 23, 2022 • 2:30 pm

Dr Penny Gilbert

Partner
Powell Gilbert LLP

Proven Strategies for Life Sciences Patent Enforcement: Protecting Patent Rights and Mastering Enforcement Procedures

February 23, 2022 • 10:00 am

Professor Dr. Maximilian Haedicke

Professor of Intellectual Property Law
Freiburg University
(Former Judge at Higher Regional Court of Duesseldorf)

Alternative Dispute Resolution for Pharma and Biotech Patent Disputes: The Shift from Ordinary Proceedings Towards ADR

February 24, 2022 • 4:00 pm

Jochen Herr

Partner
Finnegan, Henderson, Farabow, Garrett & Dunner, LLP

Preparing for the Unitary Patent and the Unified Patent Court: Thoughts on Ratification, Implementation, and Protocols for the Pharma and Biotech Industries

February 23, 2022 • 9:10 am

Rieke Kaup

Case Handler
European Commission

Global Strategies for Biosimilars and Innovator Biologics: From Patent Protection to Cost and Market Access

February 24, 2022 • 9:10 am

Daan de Lange

Partner
Brinkhof Advocaten

Compulsory Licensing: Determining Access to Medicines in the Time of the Global Pandemic

February 24, 2022 • 10:10 am

Peter Ling

Partner
Lenz & Staehelin

Compulsory Licensing: Determining Access to Medicines in the Time of the Global Pandemic

February 24, 2022 • 10:10 am

Jean-Hyacinthe de Mitry

Partner
Gide Loyrette Nouel A.A.R.P.I

Patent Enforcement Liability Towards Third Parties: What the Life Sciences Industry Needs to Know About Findings of Unjust Enrichment Due to the Invalidation of Previously Valid Patents

February 24, 2022 • 11:30 am

Miquel Montañá

Partner
Clifford Chance S.l.

Second Medical Use: Reconciling Infringement and Enforcement

February 23, 2022 • 4:30 pm

Domien Op de Beeck

Partner
Bird & Bird

Preparing for the Unitary Patent and the Unified Patent Court: Thoughts on Ratification, Implementation, and Protocols for the Pharma and Biotech Industries

February 23, 2022 • 9:10 am

André Pohlmann

Member of the 5th Board of Appeal
European Union Intellectual Property Office

Alternative Dispute Resolution for Pharma and Biotech Patent Disputes: The Shift from Ordinary Proceedings Towards ADR

February 24, 2022 • 4:00 pm

Andrea Pucci

Senior Legal & Compliance Advisor
Medicines for Europe

Robert Rodrigues

Partner
Licks Attorneys

European Supplementary Protection Certificates (SPCs): Examining Current Scope, Duration, Requirements and Assessing the Viability of a Unitary SPC

February 23, 2022 • 11:30 am

Dr. Kai Rüting

Partner
Vossius & Partner

Remedies and Alternative Measures for Life Sciences Patent Challenges: New Considerations for Injunctions, Corrective Measures, and Rules on Procurement of Evidence

February 24, 2022 • 3:00 pm

Dr. Ulrike Till

Director IP and Frontier Technologies Division
World Intellectual Property Organization (WIPO)

IP Infringement Alert: Understanding How Accelerating Drug Discovery and Development Through AI and Data Mining May Lead to Patent Challenges

February 24, 2022 • 2:00 pm

Shohta Ueno, PhD

Director, Dispute Resolution
Regeneron UK Ltd

Global Strategies for Biosimilars and Innovator Biologics: From Patent Protection to Cost and Market Access

February 24, 2022 • 9:10 am

Selma Ünlü

Senior Partner
NSN Law Firm

Remedies and Alternative Measures for Life Sciences Patent Challenges: New Considerations for Injunctions, Corrective Measures, and Rules on Procurement of Evidence

February 24, 2022 • 3:00 pm

Mikkel Vittrup

Partner
Plesner

European Supplementary Protection Certificates (SPCs): Examining Current Scope, Duration, Requirements and Assessing the Viability of a Unitary SPC

February 23, 2022 • 11:30 am

Jonas Westerberg

Partner
Westerberg & Partners Advokatbyrå AB

Second Medical Use: Reconciling Infringement and Enforcement

February 23, 2022 • 4:30 pm